Microorganisms 2022, 10, 434
13 of 14
Kapar, F.S.; Ciftci, G. The effects of curcumin and Lactobacillus acidophilus on certain hormones and insulin resistance in rats
6.
with metabolic syndrome. J. Diabetes Metab. Disord. 2020, 19, 907-914. [CrossRef] [PubMed]
7.
Ahmad, S.,; Friel, J.; Mackay, D. The effects of non-nutritive artificial sweeteners, aspartame and sucralose, on the gut microbiome
in healthy adults: Secondary outcomes of a randomized double-blinded crossover clinical trial. Nutrients 2020, 12, 3408. [CrossRef]
[PubMed]
Thomson, P.; Santibanez, R.; Aguirre, C.; Galgani, J.E.; Garrido, D. Short-term impact of sucralose consumption on the metabolic
response and gut microbiome of healthy adults. Br. J. Nutr. 2019, 122, 856-862. [CrossRef]
9.
Gerasimidis, K.; Bryden, K.; Chen, X.; Papachristou, E.; Verney, A.; Roig, M.; Hansen, R.; Nichols, B.; Papadopoulou, R.; Parrett, A.
 The impact of food additives, artificial sweeteners and domestic hygiene products on the human gut microbiome and its fibre
fermentation capacity. Eur. J. Nutr. 2020, 59, 3213-3230. [CrossRef]
10.
 American Dietetic Association DoC. Position of the American Dietetic Association and Dietitians of Canada: Nutrition and
women's health. J. Acad. Nutr. Diet. 2004, 104, 984-1001.
11.
Martyn, D.; Darch, M.; Roberts, A.; Lee, H.Y.; Yaqiong Tian, T.; Kaburagi, N.; Belmar, P. Low-/no-calorie sweeteners: A review of
global intakes. Nutrients 2018, 10, 357. [CrossRef] [PubMed]
12.
Romo-Romo, A.; Aguilar-Salinas, C.A.; Brito-Cordova, G.X.; Gomez-Diaz, R.A.; Almeda-Valdes, P. Sucralose decreases insulin
sensitivity in healthy subjects: A randomized controlled trial. Am. J. Clin. Nutr. 2018, 108, 485-491. [CrossRef]
13.
 Bueno-Hernandez, N.; Esquivel-Velazquez, M.; Alcantara-Suarez, R.; Gomez-Arauz, A.Y.; Espinosa-Flores, A.J.; de Leon-Barrera,
K.L.; Mendoza-Martinez, V.M.; Medina, G.A.S.; Leon-Hernandez, M.; Ruiz-Barranco, A.; et al. Chronic sucralose consumption
induces elevation of serum insulin in young healthy adults: A randomized, double blind, controlled trial. Nutr. J. 2020, 19, 32.
[CrossRef] [PubMed]
14.
 Peng, L.; Li, Z.R.; Green, R.S.; Holzman, I.R.; Lin, J. Butyrate enhances the intestinal barrier by facilitating tight junction assembly
via activation of AMP-activated protein kinase in Caco-2 cell monolayers. J. Nutr. 2009, 139, 1619-1625. [CrossRef] [PubMed]
15.
Chen, F.C.; Shen, K.P.; Chen, J.B.; Lin, H.L.; Hao, C.L.; Yen, H.W.; Shaw, S.Y. PGBR extract ameliorates TNF-alpha induced insulin
resistance in hepatocytes. Kaohsiung J. Med. Sci. 2018, 34, 14-21. [CrossRef]
16.
 Sender, R.; Fuchs, S.; Milo, R. Revised estimates for the number of human and bacteria cells in the body. PLoS Biol. 2016,
14, e1002533. [CrossRef]
17.
Yang, F.; Zhu, W.J.; Edirisuriya, P.; Ai, Q.; Nie, K.; Ji, J.M.; Li, Y.; Zhou, K. Beneficial effects of a combination of Clostridium
cochlearium and Lactobacillus acidophilus on body weight gain, insulin sensitivity, and gut microbiota in high-fat diet-induced
obese mice. Nutrition 2022, 93, 111439. [CrossRef]
18.
Kashtanova, D.A.; Tkacheva, O.N.; Doudinskaya, E.N.; Strazhesko, I.D.; Kotovskaya, Y.V.; Popenko, A.S.; Tyakht, A.V.; Alexeev,
 D.G. Gut microbiota in patients with different metabolic statuses: Moscow study. Microorganisms 2018, 6, 98. [CrossRef]
19.
 Caricilli, A.M.; Saad, M.J. The role of gut microbiome on insulin resistance. Nutrients 2013, 5, 829-851. [CrossRef]
20.
Gomes, A.C.; Hoffmann, C.; Mota, J.F. The human gut microbiota: Metabolism and perspective in obesity. Gut Microbes 2018, 9,
308-325. [CrossRef]
21.
 Lopetuso, L.R.; Scaldaferri, F.; Petito, V.; Gasbarrini, A. Commensal Clostridia: Leading players in the maintenance of gut
homeostasis. Gut Pathog. 2013, 5, 23. [CrossRef]
22.
 Boesmans, L.; Valles-Colomer, M.; Wang, J.; Eeckhaut, V.; Falony, G.; Ducatelle, R.; Van Immerseel, F.; Raes, J.; Verbeke, K. Butyrate
producers as potential next-generation probiotics: Safety assessment of the administration of Butyricicoccus pullicaecorum to
healthy volunteers. mSystems 2018, 3, e00094-18. [CrossRef]
23.
 Abou-Donia, M.B.; El-Masry, E.M.; Abdel-Rahman, A.A.; McLendon, R.E.; Schiffman, S.S. Splenda alters gut microflora and
increases intestinal p-glycoprotein and cytochrome p-450 in male rats. J. Toxicol. Environ. Health A 2008, 71, 1415-1429. [CrossRef]
24.
Andreasen, A.S.; Larsen, N.; Pedersen-Skovsgaard, T.; Berg, R.M.; Moller, K.; Svendsen, K.D.; Jakobsen, M.; Pedersen, B.K. Effects
of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br. J. Nutr
2010, 104,1831-1838. [Cr0ssRef]
25.
Hsieh, M.C.; Tsai, W.H. Jheng, Y.P.; Su, S.L.; Wang, S.Y.; Lin, C.C.; Chen, Y.H.; Chang, W.W. The beneficial effects of Lactobacillus
reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: A randomized, double-blinded, placebo-controlled trial. Sci.
Rep. 2018, 8, 16791. [Cr0ssRef]
26.
 Qin, X. Letter: Non-nutritive sweeteners may have a bell-shaped dose response for dysbiosis-related adverse effects that
 contributed to discrepancies between prospective cohort and randomized controlled studies. J. Obes. Metab. Syndr. 2020, 29,
237-239. [CrossRef]
Ahmad, S.Y.; Azad, M.B.; Friel J; MacKay, D. Recent evidence for the effects of nonnutritive sweeteners on glycaemic control.
27.
Cur. Opin. Clin. Nutr. Metab. Care 2019, 22, 278-283. [CrossRef] [PubMed]
28.
 Ahmad, S.Y.; Friel, J.K.; Mackay, D.S. Effect of sucralose and aspartame on glucose metabolism and gut hormones. Nutr. Reo.
2020, 78, 725-746. [CrossRef]
29.
Li, X.; Liu, Y.; Wang, Y.; Li, X.; Liu, X.; Guo, M.; Tan, Y,; Qin, X.; Wang, X. Jiang, M. Sucralose Promotes Colitis-Associated
Colorectal Cancer Risk in a Murine Model Along With Changes in Microbiota. Front. Oncol. 2020, 10, 710. [CrossRef]